Advertisement
EEII AG

EEII AG Fundamental Analysis

EEII.SWSIX
Financial ServicesAsset Management
CHF2.04
CHF0.00(0.00%)
Swiss Market opens in 50h 13m
Advertisement

EEII AG Fundamental Analysis

EEII AG (EEII.SW) shows moderate financial fundamentals with a PE ratio of -2.91, profit margin of 0.00%, and ROE of 99.64%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE99.64%
PEG Ratio0.03
Current Ratio1.72

Areas of Concern

Operating Margin0.00%
Cash Position3.16%
We analyze EEII.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 72.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
72.2/100

We analyze EEII.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

EEII.SW struggles to generate sufficient returns from assets.

ROA > 10%
-4.05%

Valuation Score

Excellent

EEII.SW trades at attractive valuation levels.

PE < 25
-2.91
PEG Ratio < 2
0.03

Growth Score

Weak

EEII.SW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

EEII.SW maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.09
Current Ratio > 1
1.72

Profitability Score

Weak

EEII.SW struggles to sustain strong margins.

ROE > 15%
99.64%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is EEII.SW Expensive or Cheap?

P/E Ratio

EEII.SW trades at -2.91 times earnings. This suggests potential undervaluation.

-2.91

PEG Ratio

When adjusting for growth, EEII.SW's PEG of 0.03 indicates potential undervaluation.

0.03

Price to Book

The market values EEII AG at -2.54 times its book value. This may indicate undervaluation.

-2.54

EV/EBITDA

Enterprise value stands at 0.00 times EBITDA. This is generally considered low.

0.00

How Well Does EEII.SW Make Money?

Net Profit Margin

For every $100 in sales, EEII AG keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $99.64 in profit for every $100 of shareholder equity.

99.64%

ROA

EEII AG generates $-4.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.05%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-1.12 in free cash annually.

$-1.12

FCF Yield

EEII.SW converts -51.46% of its market value into free cash.

-51.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.91

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.54

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.00

vs 25 benchmark

ROA

Return on assets percentage

-4.05

vs 25 benchmark

ROCE

Return on capital employed

-4.19

vs 25 benchmark

How EEII.SW Stacks Against Its Sector Peers

MetricEEII.SW ValueSector AveragePerformance
P/E Ratio-2.9120.79 Better (Cheaper)
ROE99.64%622.00% Weak
Net Margin0.00%-1174.00% (disorted) Weak
Debt/Equity-1.091.51 Strong (Low Leverage)
Current Ratio1.72935.58 Neutral
ROA-404.84%-788.00% (disorted) Weak

EEII.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews EEII AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

Fundamental Analysis FAQ